TTFields
Showing 1 - 25 of 57
Glioblastoma Trial (TTFields)
Not yet recruiting
- Glioblastoma
- TTFields
- (no location specified)
Nov 15, 2023
Compliance, Patient, Glioblastoma, Astrocytoma, Grade IV Trial (Psychological intervention)
Not yet recruiting
- Compliance, Patient
- +2 more
- Psychological intervention
- (no location specified)
Aug 23, 2023
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
TTFields in General Routine Clinical Care in Pleural
Not yet recruiting
- Pleural Mesothelioma
- TTFields
- (no location specified)
Sep 9, 2022
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)
Active, not recruiting
- Glioblastoma
- Glioblastoma, WHO Grade IV
- Temozolomide (TMZ)
- +2 more
-
Gainesville, FloridaUniversity of Florida Health
Aug 22, 2022
Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)
Not yet recruiting
- Adenocarcinoma of Lung
- NovoTTF-200T System
-
Basking Ridge, New Jersey
- +6 more
Mar 3, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Cancer
- Nab paclitaxel
- +2 more
- (no location specified)
Dec 5, 2022
GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)
Recruiting
- GBM
- +2 more
- Whole Brain Spectroscopy Imaging Array Mapping Layout
-
Philadelphia, Pennsylvania
- +1 more
Jan 19, 2023
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Recruiting
- Glioblastoma
- Tumor samples from patients treated with TTFields at initial diagnosis.
- Tumor samples from patients treated with TTFields at tumor recurrence.
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Feb 9, 2022
Glioma, Glioblastoma Trial in Wuhan (TTFields)
Not yet recruiting
- Glioma
- Glioblastoma
- TTFields
-
Wuhan, Hubei, ChinaZhongnan hospital
May 20, 2021
COVID-19 Trial in Jerusalem (NovoTTF-100L)
Completed
- COVID-19
- NovoTTF-100L
-
Jerusalem, IsraelHadassah Medical Center
Jul 4, 2021
Glioma Trial in Atlanta (Optune device)
Recruiting
- Glioma
- Optune device
-
Atlanta, Georgia
- +2 more
May 12, 2022
Glioblastoma Multiforme Trial in Prague (TTFields)
Recruiting
- Glioblastoma Multiforme
- TTFields
-
Prague, CzechiaNemocnice Na Homolce
Aug 30, 2021
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)
Recruiting
- Glioblastoma
- +2 more
- Niraparib
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 16, 2021
Astrocytoma, Grade II, Astrocytoma, Grade III Trial in United States (TTFields with adjuvant temozolomide)
Terminated
- Astrocytoma, Grade II
- Astrocytoma, Grade III
- TTFields with adjuvant temozolomide
-
Gainesville, Florida
- +4 more
Aug 26, 2021
Newly Diagnosed Glioblastoma in Patients =70 Years Trial in Heidelberg (TTFields)
Suspended
- Newly Diagnosed Glioblastoma in Patients ≥70 Years
- TTFields
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Sep 28, 2021
TTFields In GErmany in Routine Clinical Care
Unknown status
- Glioblastoma
- TTFields
-
Aschaffenburg, Bavaria, GermanyClinical center Aschaffenburg-Alzenau
Jan 27, 2021
NSCLC Trial in United States (NovoTTF-200T)
Recruiting
- Non-small Cell Lung Cancer
- NovoTTF-200T
-
Birmingham, Alabama
- +21 more
Aug 15, 2022
Recurrent Glioblastoma Multiforme Trial in Guangzhou (TTFields)
Recruiting
- Recurrent Glioblastoma Multiforme
- TTFields
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 25, 2020
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive
Not yet recruiting
- Glioblastoma
- TTFields
-
Essen, GermanyUniversity Hospital Essen
Jan 18, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023